Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110366244 | 11036624 | 4 | F | 201303 | 20160811 | 20150416 | 20160818 | EXP | US-AMGEN-USASP2015035638 | AMGEN | 74.00 | YR | E | F | Y | 0.00000 | 20160818 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 110366244 | 11036624 | 1 | PS | ENBREL | ETANERCEPT | 1 | Unknown | 50 MG, QWK | 1034025 | 103795 | 50 | MG | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | /wk | |||||
| 110366244 | 11036624 | 2 | SS | ENBREL | ETANERCEPT | 1 | 103795 | SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE | |||||||||||
| 110366244 | 11036624 | 3 | SS | ORENCIA | ABATACEPT | 1 | Unknown | UNK | 0 | ||||||||||
| 110366244 | 11036624 | 4 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 2.4 MG, QWK | 0 | 2.4 | MG | TABLET | /wk |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 110366244 | 11036624 | 1 | Rheumatoid arthritis |
| 110366244 | 11036624 | 2 | Psoriasis |
| 110366244 | 11036624 | 3 | Product used for unknown indication |
| 110366244 | 11036624 | 4 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 110366244 | 11036624 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 110366244 | 11036624 | Arthralgia | |
| 110366244 | 11036624 | Contusion | |
| 110366244 | 11036624 | Fall | |
| 110366244 | 11036624 | Fatigue | |
| 110366244 | 11036624 | Hepatic enzyme increased | |
| 110366244 | 11036624 | Impaired healing | |
| 110366244 | 11036624 | Joint injury | |
| 110366244 | 11036624 | Laboratory test abnormal | |
| 110366244 | 11036624 | Mobility decreased | |
| 110366244 | 11036624 | Nausea | |
| 110366244 | 11036624 | Osteoarthritis | |
| 110366244 | 11036624 | Peripheral swelling | |
| 110366244 | 11036624 | Precancerous skin lesion | |
| 110366244 | 11036624 | Skin cancer |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |